• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

What happened to Lennon & Retif?

















not sure about Lennon, but I believe Retif just got fed up. Same old promises every year, nothing getting done and then he had to handle his internal customers’ frustrations. He just threw in the towel.